Cyclerion Therapeutics, Inc. (CYCN): Price and Financial Metrics

Cyclerion Therapeutics, Inc. (CYCN): $2.09

0.33 (+18.75%)

POWR Rating

Component Grades

Momentum

D

Stability

D

Sentiment

Quality

C

Add CYCN to Watchlist
Sign Up

Industry: Biotech

Industry

NR

Ranked

#103 of 439

in industry

CYCN Price/Volume Stats

Current price $2.09 52-week high $5.25
Prev. close $1.76 52-week low $1.71
Day low $1.78 Volume 139,100
Day high $2.27 Avg. volume 67,693
50-day MA $2.62 Dividend yield N/A
200-day MA $2.87 Market Cap 5.66M

CYCN Stock Price Chart Interactive Chart >


Cyclerion Therapeutics, Inc. (CYCN) Company Bio


Cyclerion Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the discovering, development, and commercialization of various treatments for serious and orphan diseases. Its product candidates include Olinciguat, an orally administered vascular soluble guanylate cyclase (sGC) stimulator that is in Phase II studies for the treatment of sickle cell disease (SCD); Praliciguat, an orally administered systemic sGC stimulator that is in Phase II trials for the treatment of diabetic nephropathy and heart failure with preserved ejection fraction; and IW-6463, an orally administered central nervous system (CNS)-penetrant sGC stimulator, which is in Phase I trials for neurodegenerative diseases. The company is also discovering liver-targeted sGC and lung-targeted sGC stimulators. Cyclerion Therapeutics, Inc. was incorporated in 2018 and is headquartered in Cambridge, Massachusetts.


CYCN Latest News Stream


Event/Time News Detail
Loading, please wait...

CYCN Latest Social Stream


Loading social stream, please wait...

View Full CYCN Social Stream

CYCN Price Returns

1-mo -26.41%
3-mo -28.67%
6-mo N/A
1-year -2.79%
3-year -95.23%
5-year -94.80%
YTD -37.61%
2023 -74.47%
2022 -61.85%
2021 -43.79%
2020 12.50%
2019 N/A

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!